California State Teachers Retirement System raised its holdings in shares of Mylan N.V. (NASDAQ:MYL) by 8.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,011,681 shares of the company’s stock after purchasing an additional 80,902 shares during the period. California State Teachers Retirement System owned approximately 0.19% of Mylan N.V. worth $39,274,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. BlackRock Inc. lifted its position in Mylan N.V. by 4.5% during the second quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock valued at $1,575,089,000 after purchasing an additional 1,751,515 shares in the last quarter. Vanguard Group Inc. lifted its position in Mylan N.V. by 12.0% during the second quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock valued at $1,276,432,000 after purchasing an additional 3,531,974 shares in the last quarter. State Street Corp lifted its position in Mylan N.V. by 1.6% during the second quarter. State Street Corp now owns 20,498,541 shares of the company’s stock valued at $795,751,000 after purchasing an additional 321,977 shares in the last quarter. Pzena Investment Management LLC lifted its position in Mylan N.V. by 69.9% during the second quarter. Pzena Investment Management LLC now owns 12,339,687 shares of the company’s stock valued at $479,027,000 after purchasing an additional 5,077,371 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its position in Mylan N.V. by 7.5% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 6,922,373 shares of the company’s stock valued at $268,726,000 after purchasing an additional 480,500 shares in the last quarter. Institutional investors and hedge funds own 71.97% of the company’s stock.
Shares of Mylan N.V. (NASDAQ:MYL) traded up 0.42% during trading on Friday, reaching $37.92. 1,435,795 shares of the company were exchanged. Mylan N.V. has a 1-year low of $29.39 and a 1-year high of $45.87. The stock has a market capitalization of $20.34 billion, a P/E ratio of 30.65 and a beta of 1.30. The firm has a 50-day moving average price of $32.96 and a 200-day moving average price of $36.36.
Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by ($0.08). The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. Mylan N.V.’s revenue for the quarter was up 15.7% on a year-over-year basis. During the same period last year, the firm posted $1.16 earnings per share. Equities research analysts predict that Mylan N.V. will post $4.58 earnings per share for the current fiscal year.
MYL has been the topic of several analyst reports. Zacks Investment Research upgraded Mylan N.V. from a “sell” rating to a “hold” rating in a research report on Tuesday, August 1st. Royal Bank Of Canada set a $41.00 price target on Mylan N.V. and gave the company a “hold” rating in a report on Sunday, July 16th. Citigroup Inc. raised Mylan N.V. from a “neutral” rating to a “buy” rating and raised their price target for the company from $36.00 to $42.00 in a report on Wednesday, August 16th. Cowen and Company reissued a “hold” rating and set a $43.00 price target on shares of Mylan N.V. in a report on Thursday, August 3rd. Finally, BidaskClub raised Mylan N.V. from a “strong sell” rating to a “sell” rating in a report on Friday, June 16th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $41.21.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.